Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

Smeal, Tod, Binetruy, Bernard, Mercola, Daniel A., Birrer, Michael, Karin, Michael·1991·Nature
DOI 10.1038/354494a0

Cited by (786)

Items 601–700 of 786

  1. Systematic Assessment of the Effect of Internal Library in Targeted Analysis of SWATH-MS
    Chuan‐Qi Zhong, Rui Wu, Xi Chen, Suqin Wu, Jianwei Shuai, Jiahuai Han · 2019 · Journal of Proteome Research
  2. Transcription Factors as Targets for Cancer Therapy: AP-1 a Potential Therapeutic Target
    Virna D. Leaner, Howard Donninger, Michael Birrer · 2007 · Current Cancer Therapy Reviews
  3. Recruitment of Nuclear Factor Y to the Inverted CCAAT Element (ICE) by c-Jun and E1A Stimulates Basal Transcription of the Bone Sialoprotein Gene in Osteosarcoma Cells
    Ming Su, Anil K. Bansal, Roberto Mantovani, Jaro Sodek · 2005 · Journal of Biological Chemistry
  4. Calcium Signals and Protein Tyrosine Kinases Are Required for the Induction of c- jun in Jurkat Cells Stimulated by the T Cell-Receptor Complex and Oxidative Signals
    Liu Beiqing, Kevin V. Hackshaw, Ronald L. Whisler · 1996 · Journal of Interferon & Cytokine Research
  5. Repression of the c-Jun trans-Activation Function by the Adenovirus Type 12 E1A 52R Protein Correlates with the Inhibition of Phosphorylation of the c-Jun Activation Domain
    Dieter Brockmann, Carsten Bury, Gabriele Kröner, Hans-Christoph Kirch, Helmut Esche · 1995 · Journal of Biological Chemistry
  6. Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain
    Warren K. Hoeffler, Arthur D. Levinson, Eugene A. Bauer · 1994 · Nucleic Acids Research
  7. Genome organization and expression of the rat ACBP gene family
    Susanne Mandrup, Per Hove Andreasen, Jens Knudsen, Karsten Kristiansen · 1993 · Molecular and Cellular Biochemistry
  8. Attenuated expression of the serum responsive T1 gene in ras transformed fibroblasts due to the inhibition of c-fos gene activity
    Reto Kessler, Andrea Zacharova-Albinger, Niels Bech Laursen, Markus B. Kalousek, Roman Klemenz · 1999 · Oncogene
  9. Oncogenes and protein kinases in neuronal growth-factor action
    Kenneth W. Wood, Thomas M. Roberts · 1993 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  10. Oncoprotein phosphorylation and cell cycle control
    J Wang · 1992 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  11. Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)
    Frances Karla Kusuma, Aishvaryaa Prabhu, Galen Tieo, Syed Moiz Ahmed, Pushkar Dakle, Wai Khang Yong, Elina Pathak, Vikas Madan, Yan Yi Jiang, Wai Leong Tam et al. · 2023 · Nature Communications
  12. Ubiquitin-Proteasomal Degradation of COX-2 in TGF-β Stimulated Human Endometrial Cells Is Mediated Through Endoplasmic Reticulum Mannosidase I
    Mohan Prasad Singh, Parvesh Chaudhry, Sophie Parent, Éric Asselin · 2011 · Endocrinology
  13. The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors
    Janice M. Kraniak, Daochun Sun, Raymond R. Mattingly, John J. Reiners, Michael A. Tainsky · 2010 · Molecular and Cellular Biochemistry
  14. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis
    Ryan L. Hanson, Roger B. Brown, Maria M. Steele, Paul M. Grandgenett, James A. Grunkemeyer, Michael Anthony Hollingsworth · 2016 · Oncotarget
  15. ISO, via Upregulating MiR-137 Transcription, Inhibits GSK3β-HSP70-MMP-2 Axis, Resulting in Attenuating Urothelial Cancer Invasion
    Xirui Guo, Haishan Huang, Honglei Jin, Jiheng Xu, Sanjiv Risal, Jingxia Li, Xin Li, Huiying Yan, Xingruo Zeng, Lei Xue et al. · 2018 · Molecular Therapy — Nucleic Acids
  16. c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease
    Abigail O. Smith, Julie A. Jonassen, Kenley M. Preval, Roger J. Davis, Gregory J. Pazour · 2021 · PLoS Genetics
  17. TAF4b and Jun/Activating Protein-1 Collaborate to Regulate the Expression of Integrin α6 and Cancer Cell Migration Properties
    Μαργαρίτα Καλογεροπούλου, Angeliki Voulgari, Vassiliki Kostourou, Raphael Sandaltzopoulos, Rivka Dikstein, Irwin Davidson, Làszlò Tora, Alexander Pintzas · 2010 · Molecular Cancer Research
  18. A selective small‐molecule inhibitor of c‐Jun N‐terminal kinase 1
    Ke Yao, Yong‐Yeon Cho, Ann M. Bode, Anuradha Vummenthala, Jewn Giew Park, Kangdong Liu, Yuan‐Ping Pang, Zigang Dong · 2009 · FEBS Letters
  19. Phosphorylation of JNK is involved in regulation of H+-induced c-Jun expression
    Noriaki Shimokawa, Chun‐Hong Qiu, Takayuki Seki, Ivan Đikić, Noriyuki Koibuchi · 2003 · Cellular Signalling
  20. Cell surface heparan sulfate proteoglycans
    Sylvie Brucato, Jean Bocquet, Corinne Villers · 2002 · European Journal of Biochemistry
  21. Neurotoxic regimens of methamphetamine induce persistent expression of phospho‐c‐Jun in somatosensory cortex and substantia nigra
    Steven J. O’Dell, John F. Marshall · 2004 · Synapse
  22. Uncoupling of protein kinase D from suppression of EGF-dependent c-Jun phosphorylation in cancer cells
    Cliff Hurd, Enrique Rozengurt · 2003 · Biochemical and Biophysical Research Communications
  23. Jun N-terminal kinase activation and upregulation of p53 and p21WAF1/CIP1 in selenite-induced apoptosis of regenerating liver
    Rieko Nango, Chieko Terada, Ikuyo Tsukamoto · 2003 · European Journal of Pharmacology
  24. Myristylation-dependent transactivation by FBR v-fos is regulated by C/EBP.
    Robert M. Jotte, Nobuyuki Kamata, Jeffrey T. Holt · 1994 · Journal of Biological Chemistry
  25. Impaired jun-NH2-terminal kinase activation by ultraviolet irradiation in fibroblasts of patients with Cockayne syndrome complementation group B.
    Vineeta Dhar, Victor Adler, A. Lehmann, Ze’ev A. Ronai · 1996 · PubMed
  26. ROS Pleiotropy in Melanoma and Local Therapy with Physical Modalities
    Sanjeev Kumar Sagwal, Sander Bekeschus · 2021 · Oxidative Medicine and Cellular Longevity
  27. Enhancement of glutamatergic transmission in the cingulate cortex in response to mild noxious stimuli under a neuropathic pain‐like state
    Keiichi Niikura, Masaharu Furuya, Michiko Narita, Kazuhiro Torigoe, Yasuhisa Kobayashi, Yoshinori Takemura, Mitsuaki Yamazaki, Hiroshi Horiuchi, Tatsuya Enomoto, Masako Iseki et al. · 2010 · Synapse
  28. CD14-dependent alterations in c-Jun expression in the liver after burn injury1
    Kiho Cho, Lee K. Adamson, Jayoung Jeong, Sicily D. Crivello, Tajia G. VanHook, Tina Louise Palmieri, David G. Greenhalgh · 2004 · Journal of Surgical Research
  29. Mutational Analysis of CD28-Mediated Costimulation of Jun-N-Terminal Kinase and IL-2 Production
    Corinna Barz, Thomas Nagel, Kenneth E. Truitt, John B. Imboden · 1998 · The Journal of Immunology
  30. Protein Phosphorylation and Signal Transduction
    Sailen Barik · 1996 · Sub-cellular biochemistry/Subcellular biochemistry
  31. Involvement of G proteins, cytoplasmic calcium, phospholipases, phospholipid-derived second messengers, and protein kinases in signal transduction from mitogenic cell surface receptors
    Roy A. Frye · 1993 · Cancer treatment and research
  32. Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker
    Krishna Tiwari, Aswini Saravanan, Abhishek Anil, Vikas Kumar Tiwari, Muhammad Aaqib Shamim, Surjit Singh, Pradeep Dwivedi, Surender Deora, Shoban Babu Varthya · 2025 · Current Cardiology Reviews
  33. High affinity receptor for IgE stimulation activates protein kinase D augmenting activator protein-1 activity for cytokine producing in mast cells
    Kyoko Yamashita, Yasuhiro Gon, Toshibumi Shimokawa, Satoshi Nunomura, Daisuke Endo, Naoko Miyata, Shu Hashimoto, Johan Van Lint, Chisei Ra · 2009 · International Immunopharmacology
  34. Synaptogenesis Regulates Axotomy-Induced Activation of c-Jun-Activator Protein-1 Transcription
    Y.-J. Sung, F. Wu, Samuel Schacher, Richard T. Ambron · 2006 · Journal of Neuroscience
  35. Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity
    Kelvin Hawker, Alexander Pintzas, Robert F. Hennigan, David A. Gillespie, Brad W. Ozanne · 1993 · Journal of Virology
  36. Sensitization of Tumors to Chemotherapy Through Gene Therapy
    Ruth A. Gjerset, Dan Mercola · 2002 · Advances in experimental medicine and biology
  37. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling
    Amy E. Sprowles, Ron Wisdom · 2003 · Oncogene
  38. Impaired dynamin 2 function leads to increased AP-1 transcriptional activity through the JNK/c-Jun pathway
    Ewelina Szymańska, Agnieszka Skowronek, Marta Miączyńska · 2015 · Cellular Signalling
  39. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress
    Emma E. Croushore, Stacia L. Koppenhafer, Kelli L. Goss, Elizabeth L. Geary, David J. Gordon · 2023 · Cancer Research Communications
  40. Growth suppression of human mast cells expressing constitutively active c‐kit receptors by JNK inhibitor SP600125
    Bin Wang, Junichi Tsukada, Takehiro Higashi, Takamitsu Mizobe, Ai Matsuura, Fumihiko Mouri, Norifumi Sawamukai, Chisei Ra, Yoshiya Tanaka · 2006 · Genes to Cells
  41. Expression of Vascular Endothelial Growth Factor mRNA in GI-101A and HL-60 Cell Lines
    Ramugounder Ramakrishnan, Jason A. Zell, Andrés Malavé, Appu Rathinavelu · 2000 · Biochemical and Biophysical Research Communications
  42. Control of histone modifications
    James Davie, Virginia A. Spencer · 1999 · Journal of Cellular Biochemistry
  43. Separation of v-Src-induced mitogenesis and morphological transformation by inhibition of AP-1.
    Margaret C. Frame, Kaylene J. Simpson, Valerie J. Fincham, D H Crouch · 1994 · Molecular Biology of the Cell
  44. [24] Antisense methods for discrimination of phenotypic properties of closely related gene products: Jun kinase family
    Frédéric Bost, Robert A. McKay, Nicholas M. Dean, Olga Potapova, Dan Mercola · 2000 · Methods in enzymology on CD-ROM/Methods in enzymology
  45. Biological actions of oncogenes
    Mark R. Smith, Natasha T. Matthews, Kendra A. Jones, Hsiang‐Fu Kung · 1993 · Pharmacology & Therapeutics
  46. The Role of Oxidative Stress in Melanoma Development, Progression and Treatment
    Fabiana Henriques Machado de Melo, Fernanda Molognoni, Miriam Galvonas Jasiulionis · 2013 · InTech eBooks
  47. Upregulation of equine matrix metalloproteinase 1 by bovine papillomavirus type 1 is through the transcription factor activator protein-1
    Zhengqiang Yuan, E. A. Gault, Maria Saveria Campo, Lubna Nasir · 2011 · Journal of General Virology
  48. Alpha V Integrin Prolongs Collagenase Production Through Jun Activation Binding Protein 1
    Howard Levinson, Alok Kumar Sil, John E. Conwell, James E. Hopper, H. Paul Ehrlich · 2004 · Annals of Plastic Surgery
  49. Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway
    Ruth A. Gjerset, Habib Fakhrai, Daniel L. Shawler, Sally T. Turla, Oliver Dorigo, Amita Grover-Bardwick, Dan Mercola, Shu-Fen Wen, Heli Collins, Hong Lin et al. · 1995 · In Vitro Cellular & Developmental Biology - Animal
  50. Angiotensin II Stimulates Activation of Fos-Regulating Kinase and c-Jun NH2-Terminal Kinase in Neuronal Cultures from Rat Brain
    Xiao Chen Huang · 1998 · Endocrinology
  51. Role of NGF in axotomy‐induced c‐JUN expressionin medial septal cholinergic neurons
    Carola A. Haas, Michael Frotscher · 1998 · International Journal of Developmental Neuroscience
  52. Phosphorylation and dephosphorylation: Protein kinases A and C
    B. Gomperts, I. Kramer, P. E. Tatham · 2002 · Elsevier eBooks
  53. Mixed Lineage Kinase Phosphorylates Transcription Factor E47 and Inhibits TrkB Expression to Link Neuronal Death and Survival Pathways
    Neus Pedraza, Marta Rafel, Isis Navarro, Mario Encinas, Martí Aldea, Carme Gallego · 2009 · Journal of Biological Chemistry
  54. Comparative Proteomic Identification of Mature and Immature Sperm in the Catfish Cranoglanis bouderius
    Jintao Chen, Aiguo Zhou, Shaolin Xie, Chao Wang, Zijun Lv, Jixing Zou · 2016 · PLoS ONE
  55. Activation of c-Jun by human cytomegalovirus UL42 through JNK activation
    Tetsuo Koshizuka, Naoki Inoue · 2020 · PLoS ONE
  56. Activation of the transcription factor c-Jun in acute cellular and antibody-mediated rejection after kidney transplantation
    Akimitsu Kobayashi, Takamune Takahashi, Shigeru Horita, Izumi Yamamoto, Hiroyasu Yamamoto, Satoshi Teraoka, Kazunari Tanabe, Tatsuo Hosoya, Yutaka Yamaguchi · 2010 · Human Pathology
  57. RASSF1A suppresses oncogenic H-Ras-induced c-Jun N-terminal kinase activation
    Young A. Yoo, Ah Ram Na, Myeong Sok Lee, Sukjoon Yoon, Jun Kim · 2006 · International Journal of Oncology
  58. Azatyrosine: Mechanism of Action for Conversion of Transformed Phenotype to Normal
    Yoshiaki Monden, Fumie Hamano-Takaku, Nobuko Shindo‐Okada, Susumu Nishimura · 1999 · Annals of the New York Academy of Sciences
  59. Selective induction of p38 mitogen-activated protein kinase activity following A6H co-stimulation in primary human CD4+ T cells
    Tord Labuda, Anette Sundstedt, Mikael Dohlsten · 2000 · International Immunology
  60. Change in the molecular phenotype of Schwann cells upon transplantation into the central nervous system: down-regulation of c-jun
    Elisabetta Vaudano, G. Campbell, Stephen P. Hunt · 1996 · Neuroscience
  61. Antisense and therapeutic oligonucleotides: toward a gene-targeting cancer clinic
    Yoon S. Cho‐Chung · 2000 · Expert Opinion on Therapeutic Patents
  62. Serum-independent phosphorylation of c-Jun and alterations in AP-1 components by transformation with various oncogenes.
    Shinji Kamada, K Toyoshima, Tetsu Akiyama · 1994 · Journal of Biological Chemistry
  63. Upregulation of iHsp70 by mild heat shock protects rabbit myogenic stem cells: involvement of JNK signalling and c‐Jun
    Daiva Bironaitė, Augustas Pivoriūnas, Algirdas Venalis · 2012 · Cell Biology International
  64. Cyclosporin A and FK-506: Immunosuppression, inhibition of transcription and the role of calcineurin
    Stephen J. O’Keefe, Edward A. O’Neill · 1994 · Perspectives in Drug Discovery and Design
  65. Mutations in protein kinase subdomain X differentially affect MEKK2 and MEKK1 activity
    Jianhe Huang, Zheng Tu, Frank S. Lee · 2003 · Biochemical and Biophysical Research Communications
  66. Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells.
    Jana Kleiner, Margrit Hollborn, Peter Wiedemann, Andreas Bringmann · 2018 · Europe PMC (PubMed Central)
  67. Angiostatin K1-3 induces E-selectin via AP1 and Ets1: a mediator for anti-angiogenic action of K1-3
    Y.-H. Chen, Y.-H. HUANG, Hua‐Lin Wu, M.-P. WU, W.-T. CHANG, Y.-Z. KUO, Kai Lǚ, Li‐Wha Wu · 2008 · Journal of Thrombosis and Haemostasis
  68. Stress-activated kinases as therapeutic targets in pancreatic cancer
    Benno Traub, Aileen Roth, Marko Kornmann, Uwe Knippschild, Joachim Bischof · 2021 · World Journal of Gastroenterology
  69. Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA
    Eduardo Parra, Jorge Ferreira · 2013 · Oncology Reports
  70. Induction of phosphorylated c‐Jun in neonatal spinal motoneurons after axonal injury is coincident with both motoneuron death and regeneration
    Qiuju Yuan, Huanxing Su, Jiasong Guo, Wutian Wu, Zhi‐Xiu Lin · 2014 · Journal of Anatomy
  71. Phosphorylation and dephosphorylation
    Bastien D. Gomperts, IJsbrand M. Kramer, Peter E.R. Tatham · 2002 · Elsevier eBooks
  72. JNK1 Induces Notch1 Expression to Regulate Genes Governing Photoreceptor Production
    Mingyu Pan, Hai Hu, Rui Wang, Yi Zhou, Lele Zhang, Chen Wang, Quanyi Wang · 2019 · Cells
  73. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells
    Eduardo Parra, Luís Alberto Mora Gutiérrez, Jorge Ferreira · 2014 · Oncology Reports
  74. Transcription Factor Activation in Human Neutrophils
    Alexandre Cloutier, Patrick P. McDonald · 2003 · KARGER eBooks
  75. Activation of c-Jun and ATF-2 in primate motor cranial nerve nuclei is not associated with apoptosis following axotomy
    Geoffrey Philip Colby, Alexander Lewis Coon, Edward Sander Connolly, Richard T. Ambron · 2005 · Experimental Neurology
  76. Apoptosis induced by 5-(N,N-hexamethylene)-amiloride in regenerating liver after partial hepatectomy
    Tomoko Suzuki, Ikuyo Tsukamoto · 2004 · European Journal of Pharmacology
  77. The transactivation potential of a c-Myc N-terminal region (residues 92- 143) is regulated by growth factor/Ras signaling
    Michael S. Colman · 1996 · Nucleic Acids Research
  78. JUN mRNA translation regulation is mediated by multiple 5’ UTR and start codon features
    Angélica M. González-Sánchez, Eimy A. Castellanos-Silva, Gabriela Díaz-Figueroa, Jamie H. D. Cate · 2024 · PLoS ONE
  79. Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK).
    Nancy Dos Santos, Golareh Habibi, Michelle Y. Wang, Jennifer H. Law, Heather N. Andrews, Daniel Hsiang Wei, Timothy Junius Triche, Shoukat Dedhar, Sandra Elaine Dunn · 2007 · Europe PMC (PubMed Central)
  80. Transcriptional Activation of the CEF-4/9E3 Cytokine Gene by pp60 v- src
    Mohammed Dehbi, Angelique Ndjoyi Mbiguino, Myriam Beauchemin, Gilles Chatelain, Pierre‐André Bédard · 1992 · Molecular and Cellular Biology
  81. C-Jun phosphorylation (Ser-63) in the testis of the lizard, Podarcis s. sicula
    Paolo Chieffi, Antonietta Picascia, Rosita Stanzione, Donatella Tramontano · 1999 · Journal of Endocrinology
  82. Peroxisome Proliferators and Cytochrome P4504A Inductiona
    G. Gordon Gibson · 1996 · Annals of the New York Academy of Sciences
  83. MEK Inhibition in Glioblastoma: Current Perspectives and Future Directions
    Adam Shapira Levy, Jean-Paul Bryant, David P. Matichak, Shumpei Onishi, Yeshavanth Banasavadi‐Siddegowda · 2025 · International Journal of Molecular Sciences
  84. The SARS-CoV2 and mitochondria: the impact on cell fate.
    Eleonora Madeddu, Barbara Maniga, Marco Zaffanello, Vassilios Fanos, Antonietta Marcialis · 2022 · PubMed Central
  85. Anti-proliferative Effect of C3 Exoenzyme in Fibroblasts is Mediated by c-Jun Phosphorylation
    Leonie von Elsner, Sandra Hagemann, Ingo Just, Astrid Rohrbeck · 2017 · Journal of Molecular Signaling
  86. Interleukin‐6‐Type Cytokines in Myeloproliferative Diseasea
    Robert G. Hawley · 1995 · Annals of the New York Academy of Sciences
  87. The defective transforming phenotype of c-Jun Ala63/73 is rescued by mutation of the C-terminal phosphorylation site
    Frédéric Bost, Leslie Caron, Emmanuel Vial, Nicole Montreau, Irène Marchetti, Valérie Dejong, Libert H.K. Defize, Marc Castellazzi, Bernard Binétruy · 2001 · Oncogene
  88. Nuclear Onco‐Protein Targets of Signal Transduction Pathways
    James Robert Woodgett, Bernd Pulverer, Simon Edward Plyte, Kenneth Hughes, Eleni Nikolakaki · 1994 · Pigment Cell Research
  89. The role of Jun kinases in apoptosis
    Steven P. Tammariello, Gary E. Landreth, Steven Estus · 2001 · Advances in cell aging and gerontology
  90. ZBTB7B is a permissive regulator of hepatocellular carcinoma initiation by repressing c-Jun expression and function
    Yue Zhu, Qinqin Wang, Xinyu Xie, Cuihong Ma, Yuemei Qiao, Yu Zhang, Yanjun Wu, Yuan Gao, Jing Shan Jiang, Xin Liu et al. · 2024 · Cell Death and Disease
  91. A 5′-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling
    Nancy G. Pedigo, Hongxing Zhang, Maria E. C. Bruno, Charlotte Slayton Kaetzel, Amy R Dugan, Piam Shanehsaz, Robert F. Hennigan, Zhenlan Xing, Nicholas J. Koszewski, David M. Kaetzel · 2004 · Oncogene
  92. Protein Kinase C in Oncogenic Transformation and Cell Polarity
    IJsbrand M. Kramer · 2015 · Elsevier eBooks
  93. Transcription factors as targets for drug development
    Devarajan Karunagaran, Bharat Bhushan Aggarwal · 2002 · CRC Press eBooks
  94. Jun: the master regulator in healthy and cancer cells
    Petr Vaňhara, Jan Šmarda · 2006 · Journal of Applied Biomedicine
  95. Reactive Oxygen Species Are Possibly Involved in the Mechanism of Flumequine-Induced Hepatocarcinogenesis in Mice
    Yusuke Kenmochi, Miwa Takahashi, Mitsuyoshi Moto, Masako Muguruma, Jihei Nishimura, Meilan Jin, Taichi Kohno, Yusuke Yokouchi, Kunitoshi Mitsumori · 2007 · Journal of Toxicologic Pathology
  96. Enhanced Expression of WD Repeat-Containing Protein 35 via Nuclear Factor-Kappa B Activation in Bupivacaine-Treated Neuro2a Cells
    Lei Huang, Fumio Kondo, Misako Harato, Guo‐Gang Feng, Naoshisa Ishikawa, Yoshihiro Fujiwara, Shoshiro Okada · 2014 · PLoS ONE
  97. Interleukin 1 activation of the AP-1 transcription complex in murine T cells is regulated at the level of Jun B protein accumulation
    James W. Brooks, Barbara K. Yoza, Steven B. Mizel · 1995 · Molecular Immunology
  98. Signalling intermediates of CD28
    Yinon Ben‐Neriah, Irit Alkalay, Avraham Yaron, Ada Hatzubai, Steffen Jung · 1995 · Research in Immunology
  99. Presentation at the National Asthma Campaign International Congress, June 1999Controlling the inflammatory response through transcriptional mechanisms
    Paul Lavender, David J. Cousins, P. Smith, T. Lee · 2000 · Clinical & Experimental Allergy
  100. The evolution of JNK inhibition: A review on modern targeting strategies
    Jie Li, Lin Cao, Yinglai Yang, Ying Gao, Baojian Li, Nanqi Shao, Zheng Ran, Lu Luo · 2026 · European Journal of Medicinal Chemistry